IRCT20111107008022N5
Recruiting
未知
Comparative bioequivalence study of two different Metformin 750mg formulations (Koushan pharmed & reference) in 24 Iranian volunteers
Kushan Pharmed Company0 sites24 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health and normal volunteers.
- Sponsor
- Kushan Pharmed Company
- Enrollment
- 24
- Status
- Recruiting
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •24 healthy male and female volunteers will participate in this study. Aged 18 to 45 years, based on laboratory safety tests, no history of diseases affecting drug pharmacokinetic processes; lack of any chronic or acute medication at least 1 week before the start of the study, adherence to the criteria on the basis of moral obligation and signed an informed consent; actual weight (TBW) in the range of 20% IBW Exclusion criteria: Age outside the range mentioned; acute or chronic smoking or alcohol, failure to obtain any of the above health tests, medication two weeks before the experiment
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Bioequivalency study of two different Metformin formulationsIRCT20111107008022N7Reihaneh Pharmaceutical Company24
Not yet recruiting
Not Applicable
Bioequivalence study of two different Ciprofloxacin formulationsIRCT20111107008022N13Zagrous Darou Pharmaceutical Company24
Not yet recruiting
Not Applicable
Bioequivalence study of two different Fenofibrate formulationsIRCT20111107008022N10Aviccena Pharmaceutical Company24
Recruiting
Not Applicable
Bioequivalency study of two different Pantoprazole formulationsHealth volunteers.IRCT20111107008022N8Exir Pharmaceutical Company24
Recruiting
Not Applicable
Bioequivalence study of two different Metformin formulationsIRCT20111107008022N9Sobhandarou24